Noblett Karen
Chief Medical Officer at Axonics, Inc.
- Sold, on record
- $7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jan 31, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Axonics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Axonics, Inc.Plan not statedMar 18, 2022 2022
Sold 13,531 shares at $57.23 ($774k)
Noblett Karen, Chief Medical Officer
Sold 24.3% of holdings ($3.2M position)42,053 shares leftFiling
- 2 Form 4 sale Axonics, Inc.Plan not statedSep 7, 2022 +173 days
Sold 10,454 shares at $71.53 ($748k)
Noblett Karen, Chief Medical Officer
Sold 24.9% of holdings ($3M position)31,599 shares leftFiling
- 3 Form 4 sale Axonics, Inc.UnusualSep 12, 2022 +5 days
Sold 32,483 shares at $78.16 ($2.5M)
Noblett Karen, Chief Medical Officer
Sold 50.7% of holdings ($5M position)31,599 shares left3.1x usual sizeFiling
- 4 Form 4 sale Axonics, Inc.Plan not statedFeb 1, 2023 +142 days
Sold 4,634 shares at $61.11 ($283k)
Noblett Karen, Chief Medical Officer
Sold 9.9% of holdings ($2.9M position)42,215 shares left0.4x usual sizeFiling
- 5 Form 144 notice Axonics, Inc.NoticeDec 26, 2023 +328 days
Filed to sell 23,999 shares ($1.6M)
Noblett Karen, Officer
10b5-1 plan2.3x usual sizeFiling
- 6 Form 4 sale Axonics, Inc.RoutineDec 28, 2023 +2 days
Sold 8,000 shares at $63.25 ($506k)
Noblett Karen, Chief Medical Officer
10b5-1 planSold 19% of holdings ($2.7M position)34,215 shares left0.8x usual sizeFollows a Form 144Filing
- 7 Form 4 sale Axonics, Inc.RoutineJan 8, 2024 +11 days
Sold 15,999 shares at $69.00 ($1.1M)
Noblett Karen, Chief Medical Officer
10b5-1 planSold 46.8% of holdings ($2.4M position)18,216 shares left1.7x usual sizeFollows a Form 144Filing
- 8 Form 4 sale Axonics, Inc.No planJan 31, 2024 +23 days
Sold 11,288 shares at $67.74 ($765k)
Noblett Karen, Chief Medical Officer
No 10b5-1 planSold 24.7% of holdings ($3.1M position)34,428 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Feb 2, 2024 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 11,288 | $765k | 24.7% | No plan | SEC |
| Jan 8, 2024 | Jan 10, 2024 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 15,999 | $1.1M | 46.8% | Routine | SEC |
| Dec 28, 2023 | Dec 28, 2023 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 8,000 | $506k | 19.0% | Routine | SEC |
| Dec 26, 2023 | Dec 26, 2023 | Axonics, Inc. | Officer | Form 144 notice | 23,999 | $1.6M | Notice | SEC | |
| Feb 1, 2023 | Feb 2, 2023 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 4,634 | $283k | 9.9% | Plan not stated | SEC |
| Sep 12, 2022 | Sep 20, 2022 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 32,483 | $2.5M | 50.7% | Unusual | SEC |
| Sep 7, 2022 | Sep 9, 2022 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 10,454 | $748k | 24.9% | Plan not stated | SEC |
| Mar 18, 2022 | Mar 22, 2022 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 13,531 | $774k | 24.3% | Plan not stated | SEC |
| Feb 3, 2022 | Feb 3, 2022 | Axonics, Inc. | Chief Medical Officer | Form 4 sale | 6,682 | $322k | 10.7% | Plan not stated | SEC |